MUC1 and breast carcinoma: Apostolopoulos et al. (1993) succeeded to produce monoclonal antibodies against breast cancer using a glutathione-s-transferase-MUC1 bacterial fusion protein providing a useful diagnostic or therapeutic agent for breast cancer.